Apoptosis is a Critical Cellular Event in Cancer Chemoprevention and Chemotherapy by Selenium Compounds

Current Cancer Drug Targets

Volumn 4, Issue 1, 2004, Pages 13-28

  Sinha, R ^a   El Bayoumy, K ^a  

^a AMERICAN HEALTH FOUNDATION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

1,4 OXSELENIN; 1,4 PHENYLENEBIS(METHYLENE)SELENOCYANATE; ALLYLSELENOCYSTEINE; ALPHA TOCOPHEROL; BENZYL SELENOCYANATE; CELL CYCLE PROTEIN; EBSELEN; GLUTATHIONE; GLUTATHIONE DERIVATIVE; METHYL SELENOCYANATE; METHYLSELENINIC ACID; METHYLSELENOCYSTEINE; MITOCHONDRIAL PROTEIN; MOLECULAR MARKER; ORGANOSELENIUM DERIVATIVE; POLYAMINE; POTASSIUM SELENOCYANATE; PROPYLSELENOCYSTEINE; PROTEINASE; REGULATOR PROTEIN; SELENIUM DERIVATIVE; SELENOBETAINE; SELENOCYSTAMINE; SELENODIGLUTATHIONE; SELENOMETHIONINE; SELENOXIDE; SODIUM SELENITE; TRANSCRIPTION FACTOR; TRIPHENYLSELENONIUM CHLORIDE; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ANIMAL CELL; APOPTOSIS; CANCER CHEMOTHERAPY; CANCER PREVENTION; CARCINOGENESIS; CELL PROLIFERATION; DRUG EFFICACY; DRUG POTENCY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PROTEIN EXPRESSION; RAT; REVIEW; TARGET ORGAN; TUMOR SUPPRESSOR GENE;

ANIMALS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CHEMOPREVENTION; HUMANS; NEOPLASMS; SELENIUM COMPOUNDS;

EID: 1542724502     PISSN: 15680096     EISSN: None     Source Type: Journal    
DOI: 10.2174/1568009043481614     Document Type: Review

References (207)

1. Doll, R.; Peto, R. The Causes of Cancer: Oxford University Press: New York, 1981.
2. Weinstein, I.B. Cancer Prevention: Recent Progress and Future Opportunities. Cancer Res. 1991, 51, 5080s-5085s.
3. Weinstein, I. B.; Santella, R.M.; Perera, F. P. In Cancer Prevention and Control: Greenwald, P.; Kramer, B. S.; Weed, D. L., Eds.; Marcel Dekker: NY, 1995, pp. 83-110.
4. Weinstein, I. B.; Carothers, A.M.; Santella, R. M.; Perera, F. P. In The Molecular Basis of Cancer: Mendelsohn, J.; Howley, P. M.; Israel, M. A.; Liotta, L. A., Eds.; W.B Saunders: PA, 1995, pp. 59-85.
5. Wynder, E. L. The Past, Present, and Future of the Prevention of Lung Cancer. Cancer Epidemiol. Biomarkers Prev. 1998, 7, 735-748.
6. Verkasalo, P. K.; Kaprio, J.; Koskenvuo, M.; Pukkala, E. Genetic Predisposition, Environment and Cancer Incidence; A Nationwide Twin Study in Finland, 1976-1995. Int. J. Cancer 1999, 83, 743-749.
7. Thomas, D. C. Genetic Epidemiology with a Capital "E". Genet. Epidemiol, 2000, 19, 289-300.
8. http://www.nyu.edu/education/ot/no.smoking.htm
9. National Cancer Institute. Population Based Smoking Cessation: Proceedings of a Conference on What Works to Influence Cessation in the General Population. Smoking and Tobacco Control Monograph No. 12, MD: U.S. Department of Health and Human Services, National Institutes of Health, National Cancer Institute, NIH Pub. No. 00-4892, November 2000.
10. Clark, L. C.; Combs, G. F., Jr.; Turnbull, B. W.; Slate, E. H.; Chalker, D. K.; Chow, J.; Davis, L. S.; Glover, R. A.; Graham, G. F.; Gross, E. G.; Krongrad, A.; Lesher, J. L., Jr.; Park, H. K.; Sanders, B. B. Jr.; Smith, C. L. ; Taylor, J. R. Effects of Selenium Supplementation for Cancer Prevention in Patients With Carcinoma of the Skin. A Randomized Controlled Trial. Nutritional Prevention of Cancer Study Group. J. Am. Med. Assoc. 1996, 276, 1957-1963.
11. Duffield-Lillico, A. J.; Reid, M. E.; Turnbull, B. W.; Combs, G. F., Jr. ; Slate, E. H.; Fischbach, L. A.; Marshall, J. R.; Clark, L. C. Baseline Characteristics and the Effect of Selenium Supplementation on Cancer Incidence in a Randomized Clinical Trial: a Summary Report of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 630-639.
12. Reid, M. E.; Duffield-Lillico, A. J.; Garland, L.; Turnbull, B. W.; Clark, L. C.; Marshall, J. R. Selenium Supplementation and Lung Cancer Incidence: An Update of the Nutritional Prevention of Cancer Trial. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1285-1291.
13. Nelson, A. A.; Fitzhugh, O. G.; Calvery, H. O. Liver Tumors Following Cirrhosis Caused by Selenium in Rats. Cancer Res. 1943, 3, 230-236.
14. Rotruck, J. T.; Pope, A. L.; Ganther, H. E.; Swanson, A. B.; Hafeman, D. G.; Hoekstra, W. G. Selenium: Biochemical Role as a Component of Glutathione Peroxidase. Science 1973, 179, 588-590.
15. Takahashi, K.; Cohen, H. J. Selenium-Dependent Glutathione Peroxidase Protein and Activity: Immunological Investigations on Cellular and Plasma Enzymes. Blood 1986, 68, 640-645.
16. Ursini, F.; Maiorino, M.; Gregolin, C. The Selenoenzyme Phospholipid Hydroperoxide Glutathione Peroxidase. Biochim. Biophys. Acta 1985, 839, 62-70.
17. Chu, F. F.; Doroshow, J. H.; Esworthy, R. S. Expression, Characterization, and Tissue Distribution of a New Cellular Selenium-Dependent Glutathione Peroxidase, GSHPx-G1. J. Biol. Chem. 1993, 268, 2571-2576.
18. Arthur, J. R.; Nicol, F.; Beckett, G. J. Hepatic Iodothyronine 5′-Deiodinase. The Role of Selenium. Biochem. J. 1990, 272, 537-540.
19. Davey, J. C.; Becker, K. B.; Schneider, M. J.; St Germain, D. L.; Galton, V. A. Cloning of a cDNA for the Type II Iodothyroninc Deiodinase. J. Biol. Chem. 1995, 270, 26786-26789.
20. Croteau, W.; Whittemore, S. L.; Schneider, M. J.; St Germain, D. L. Cloning and Expression of a cDNA for a Mammalian Type III Iodothyronine Deiodinase. J. Biol. Chem 1995, 270, 16569-16575.
21. Larsen, P. R.; Berry, M. J. Nutritional and Hormonal Regulation of Thyroid Hormone Deiodinases. Annu. Rev. Nutr. 1995, 15, 323-352.
22. Tamura, T.; Stadtman, T. C. A New Selenoprotein from Human Lung Adenocarcinoma Cells: Purification, Properties, and Thioredoxin Reductase Activity. Proc. Natl. Acad. Sci. U.S.A. 1996, 93, 1006-1011.
23. Akesson, B.; Bellew, T.; Burk, R. F. Purification of Selenoprotein P from Human Plasma. Biochim. Biophys. Acta 1994, 1204, 243-249.
24. Vendeland, S. C.; Beilstein, M. A.; Yeh, J. Y.; Ream, W.; Whanger, P. D. Rat Skeletal Muscle Selenoprotein W: cDNA Clone and mRNA Modulation by Dietary Selenium. Proc. Natl. Acad. Sci. U.S.A. 1995, 92, 8749-8753.
25. Gladyshev, V. N. In Selenium, its Molecular Biology, and Role in Human Health; Hatfield, D. L., Ed; Kluwer Academic Publishers: MA, 2001, pp. 99-114.
26. Burk, R. F. Molecular Biology of Selenium with Implications for its Metabolism. FASEB J. 1991, 5, 2274-2279.
27. Stadtman, T. C. Selenocysteine. Annu. Rev. Biochem. 1996, 65, 83-100.
28. Shamberger, R. J.; Frost, D. V. Possible Protective Effect of Selenium Against Human Cancer. Can. Med. Assoc. J. 1969, 100, 682.
29. Sharma, K.; Mittal, D. K.; Kesarwani, R. C.; Kamboj, V. P.; Chowdhery, R. Diagnostic and Prognostic Significance of serum and tissue trace elements in breast malignancy. Indian J. Med. Sci. 1994, 48, 227-232.
30. Guo, W. D.; Chow, W. H.; Zheng, W.; Li, J. Y.; Blot, W. J. Diet, Serum Markers and Breast Cancer Mortality in China. Jpn. J. Cancer Res. 1994, 85, 572-577.
31. Huang, Y. L.; Sheu, J. Y.; Lin, T. H. Association Between Oxidative Stress and Changes of Trace Elements in Patients with Breast Cancer. Clin. Biochem. 1999, 32, 131-136.
32. Burney, P. G.; Comstock, G. W.; Morris, J. S. Pancreatic Cancer. J. Clin. Nutr. 1997, 49, 895-900.
33. Glattre, E.; Thomassen, Y.; Haldorsen, T.; Lund-Larsen, P. G.; Theodorsen, L.; Aaseth, J. Prediagnostic Serum Selenium in a Case-Control Study of Thyroid Cancer. Int. J. Epidemiol. 1989, 18, 45-49.
34. Jaskiewicz, K.; Marasas, W. F.; Rossouw, J. E.; Van Niekerk, F. E.; Heine Tech, E. W. P. Selenium and Other Mineral Elements in Populations at Risk for Esophageal Cancer. Cancer 1988, 62, 2635-2639.
35. Knekt, P.; Aromaa, A.; Maatela, J.; Alfthan, G.; Aaran, R. K.; Hakama, M.; Hakulinen, T.; Peto, R.; Teppo, L. Serum Selenium and Subsequent Risk of Cancer among Finnish Men and Women. J. Natl. Cancer Inst. 1990, 82, 864-868.
36. Westin, T.; Ahlbom, E.; Johansson, E.; Sandstrom, B.; Karlberg, I.; Edstrom S. Circulating Levels of Selenium and Zinc in Relation to Nutritional Status in Patients with Head and Neck Cancer. Arch. Otolaryngol. Head Neck Surg. 1989, 115, 1079-1082.
37. Philipov, P.; Tzatchev, K. Selenium Concentrations in Serum of Patients with Cerebral and Extracerebral Tumors. Zentralbl. Neurochir. 1988, 49, 344-347.
38. Menkes, M. S.; Comstock, G. W.; Vuilleumier, J. P.; Helsing, K. J.; Rider, A. A.; Brookmeyer, R. Serum Beta-Carotene, Vitamins A and E, Selenium, and the Risk of Lung Cancer. New Engl. J. Med. 1986, 315, 1250-1254.
39. Nomura, A.; Heilbrun, L. K.; Morris, J. S.; Stemmermann, G. N. Serum Selenium and the Risk of Cancer, by Specific Sites: Case-Control Analysis of Prospective Data. J. Natl. Cancer Inst. Cancer Inst. 1987, 79, 103-108.
40. Ringstad, J.; Jacobsen, B. K.; Tretli, S; Thomassen, Y. Serum Selenium Concentration Associated with Risk of Cancer. J. Clin. Pathol. 1988, 41, 454-457.
41. Garland, M.; Morris, J. S.; Stampfer, M. J.; Colditz, G. A.; Spate, V. L.; Baskett, C. K.; Rosner, B.; Speizer, F. E.; Willett, W. C.; Hunter, D. J. Prospective Study of Toenail Selenium Levels and Cancer Among Women. J. Natl. Cancer Inst. 1995, 87, 497-505.
42. Ip, C. Lessons From Basic Research in Selenium and Cancer Prevention. J. Nutr. 1998, 128, 1845-1854.
43. Combs, G. F., Jr.; Gray, W. P. Chemopreventive Agents: Selenium. Pharmacol. Ther. 1998, 79, 179-192.
44. El-Bayoumy, K. The Protective Role of Selenium on Genetic Damage and on Cancer. Mutat. Res. 2001, 475, 123-139.
45. Jacobs, M.; Forst, C. Toxicological Effects of Sodium Selenite in Sprague-Dawley Rats. J. Toxicol Environ. Health 1981, 8, 575-585.
46. Ip, C. The Chemopreventive Role of Selenium in Carcinogenesis. Adv. Exp. Med. Biol. 1986, 206, 431-447.
47. Medina, D.; Morrison, D. G. Current Ideas on Selenium As a Chemopreventive Agent. Pathol. Immunopathol. Res. 1988, 7, 187-199.
48. El-Bayoumy, K. In Cancer Principles and Practice of Oncology; DeVita, V. T.; Hellman, S.; Rosenberg, S. S., Eds,; J. B. Lippincott: Philadelphia, PA, 1991, pp. 1-15.
49. Combs, G. F., Jr. In Antioxidants and Disease Prevention: Garewal, H.S., Ed.; CRC Press: New York, NY, 1997, pp. 97-113.
50. Ip, C.; Thompson, H. J.; Ganther, H. E. Activity of Triphenylselenonium Chloride in Mammary Cancer Prevention. Carcinogenesis 1994, 15, 2879-2882.
51. Ip, C.; Lisk, D. J.; Ganther, H. E. Activities of Structurally-Related Lipophilic Selenium Compounds as Cancer Chemopreventive Agents. Anticancer Res. 1998, 18, 4019-4025.
52. Medina, D.; Thompson, H. J.; Ganther, H. E.; Ip, C. Semethylselenocysteine: A New Compound for Chemoprevention of Breast Cancer. Nutr. Cancer 2001, 40, 12-17.
53. Ip, C.; Dong, Y. Methylselenocysteine Modulates Proliferation and Apoptosis Biomarkers in Premalignant Lesions of the Rat Mammary, Gland. Anticancer Res. 2001, 21, 863-867.
54. El-Bayoumy, K.; Narayanan, B. A.; Desai, D. H.; Narayanan, N. K.; Pittman, B.; Amin, S. G.; Schwartz, J.; Nixon, D. W. Elucidation of Molecular Targets of Mammary Cancer Chemoprevention in the Rat by Organoselenium Compounds using cDNA Microarray. Carcinogenesis 2003, 24, 1505-1514.
55. Ip, C.; Hayes, C. Tissue Selenium Levels in Selenium-Supplemented Rats and Their Relevance in Mammary Cancer Protection. Carcinogenesis 1989, 10, 921-925.
56. Finley, J. W.; Ip, C.; Lisk, D. J.; Davis, C. D.; Hintze, K. J.; Whanger, P. D. Cancer-Protective Properties of High-Selenium Broccoli. J. Agric. Food Chem. 2001, 49, 2679-2683.
57. Ip, C.; Lisk, D. J. Efficacy of Cancer Prevention by High-Selenium Garlic Is Primarily Dependent on the Action of Selenium. Carcinogenesis 1995, 16, 2649-2652.
58. Whanger, P. D.; Ip, C.; Polan, C. E.; Uden, P. C.; Welbaum, G. Tumorigenesis, Metabolism, Speciation, Bioavailability, and Tissue Deposition of Selenium in Selenium-Enriched Ramps (Allium Tricoccum). J. Agric. Food Chem. 2000, 48, 5723-5730.
59. Ganther, H. E. Selenium Metabolism, Selenoproteins and Mechanisms of Cancer Prevention: Complexities With Thioredoxin Reductase. Carcinogenesis 1999, 20, 1657-1666.
60. Allan, C. B.; Lacourciere, G. M.; Stadtman, T. C. Responsiveness of Selenoproteins to Dietary Selenium. Annu. Rev. Nutr. 1999, 19, 1-16.
61. Mustacich, D.; Powis, G. Thioredoxin Reductase. Biochem. J. 2000, 346, 1-8.
62. Behne, D.; Kyriakopoulos, A. Mammalian Selenium-Containing Proteins. Annu. Rev. Nutr. 2001, 21, 453-473.
63. McKenzie, R. C.; Arthur, J. R.; Beckett, G. J. Selenium and the Regulation of Cell Signaling, Growth, and Survival: Molecular and Mechanistic Aspects. Antioxid. Redox. Signal. 2002, 4, 339-351.
64. Foiles, P. G.; Fujiki, H.; Suganuma, M.; Okabe, S.; Yatsunami, J.; Miglietta, L. M.; Upadhyaya, P.; El-Bayoumy, K.; Ronai, Z. Inhibition of PKC and PKA by Chemopreventive Organoselenium Compounds. Int. J. Oncol. 1995, 7, 685-690.
65. Gopalakrishna, R.; Gundimeda, U. Protein Kinase C as a Molecular Target for Cancer Prevention by Selenocompounds. Nutr. Cancer 2001, 40, 55-63.
66. Stapleton, S. R.; Garlock, G. L.; Foellmi-Adams, L.; Kletzien, R. F. Selenium: Potent Stimulator of Tyrosyl Phosphorylation and Activator of MAP Kinase. Biochim. Biophys. Acta 1997, 1355, 259-269.
67. Sinha, R.; Kiley, S. C.; Lu, J. X.; Thompson, H. J.; Moraes, R.; Jaken, S.; Medina, D. Effects of Methylselenocysteine on PKC Activity, cdk2 Phosphorylation and gadd Gene Expression in Synchronized Mouse Mammary Epithelial Tumor Cells. Cancer Lett. 1999, 146, 135-145.
68. Fiala, E. S.; Joseph, C.; Sohn, O. S.; El Bayoumy, K.; Reddy, B. S. Mechanism of Benzylselenocyanate Inhibition of Azoxymethane-Induced Colon Carcinogenesis in F344 Rats. Cancer Res. 1991, 51, 2826-2830.
69. Sohn, O. S.; Fiala, E. S.; Upadhyaya, P.; Chae, Y. H.; El Bayoumy, K. Comparative Effects of Phenylenebis (Methylene) Selenocyanate Isomers on Xenobiotic Metabolizing Enzymes in Organs of Female CD Rats. Carcinogenesis 1999, 20, 615-621.
70. Tanaka, T.; Makita, H.; Kawabata, K.; Mori, H.; El-Bayoumy, K. 1,4-Phenylenebis (Methylene) Selenocyanate Exerts Exceptional Chemopreventive Activity in Rat Tongue Carcinogenesis. Cancer Res. 1997, 57, 3644-3648.
71. Kretz-Remy, C.; Arrigo, A. P. Selenium: a Key Element That Controls NF-κB Activation and IκBα Half Life. Biofactors 2001, 14, 117-125.
72. Youn, B. W.; Fiala, E. S.; Sohn, O. S. Mechanisms of Organoselenium Compounds in Chemoprevention: Effects on Transcription Factor-DNA Binding. Nutr. Cancer 2001, 40, 28-33.
73. Kaeck, M.; Lu, J.; Strange, R.; Ip, C.; Ganther, H. E.; Thompson, H.J. Differential Induction of Growth Arrest Inducible Genes by Selenium Compounds. Biochem. Pharmacol. 1997, 53, 921-926.
74. Spyrou, G.; Bjornstedt, M.; Kumar, S.; Holmgren, A. AP-1 DNA-Binding Activity is Inhibited by Selenite and Selenodiglutathione. FEBS Lett. 1995, 368, 59-63.
75. Fiala, E. S.; Staretz, M. E.; Pandya, G. A; El-Bayoumy, K.; Hamilton, S.R. Inhibition of DNA Cytosine Methyltransferase by Chemopreventive Selenium Compounds, Determined by an Improved Assay for DNA Cytosine Methyltransferase and DNA Cytosine Methylation. Carcinogenesis 1998, 19, 597-604.
76. Jiang, C.; Jiang, W.; Ip, C.; Ganther, H. E.; Lu, J. Selenium-Induced Inhibition of Angiogenesis in Mammary Cancer at Chemopreventive Levels of Intake. Mol. Carcinog. 1999, 26, 213-225.
77. Lanfear, J.; Fleming, J.; Wu, L.; Webster, G.; Harrison, P. R. The Selenium Metabolite Selenodiglutathione Induces p53 and Apoptosis: Relevance to the Chemopreventive Effects of Selenium? Carcinogenesis 1994, 15, 1387-1392.
78. 2 Induces Apoptosis with Down-Regulation of Bcl-2 and Up-Regulation of p53 Expression in Both Immortal Human Hepatic Cell Line and Hepatoma Cell Line. Mutat. Res. 2001, 490, 113-121.
79. Seo, Y. R.; Kelley, M. R.; Smith, M. L. Selenomethionine Regulation of p53 by a Refl-Dependent Redox Mechanism. Proc. Natl. Acad Sci. U.S.A. 2002, 99, 14548-14553.
80. Kiremidjian-Schumacher, L.; Roy, M. Selenium and Immune Function. Z. Ernahrungswiss. 1998, 37, 50-56.
81. McKenzie, R. C.; Rafferty, T. S.; Beckett, G. J. Selenium: An Essential Element for Immune Function. Immunol. Today 1998, 19, 342-345.
82. Wyllie, A. H. Apoptosis (the 1992 Frank Rose Memorial Lecture). Br. J. Cancer 1993, 67, 205-208.
83. Thompson, C. B. Apoptosis in Pathogenesis and Treatment of Disease. Science 1995, 267, 1456-1462.
84. Green, D. R. Apoptotic Pathways:Paper Wraps Stone Blunts Scissors. Cell 2000, 102, 1-4.
85. Wang, X. The Expanding Role of Mitochondria in Apoptosis. Genes Dev. 2001, 15, 2922-2933.
86. Suzuki, Y.; Imai, Y.; Nakayama, H.; Takahashi, K.; Takio, K; Takahashi, R. A Serine Protease, Htra2, is Released from the Mitochondria and Interacts with XIAP, Inducing Cell Death. Mol. Cell. 2001, 8, 613-621.
87. Adams, J. M.; Cory, S. The Bcl-2 Protein Family: Arbiters of Cell Survival. Science 1998, 281, 1322-1326.
88. Huang, D. C.; Strasser, A. BH3-only Proteins-Essential Initiators of Apoptotic Cell Death. Cell 2000, 103, 839-842.
89. Johnstone, R. W.; Ruefli, A. A; Lowe, S. W. Apoptosis: A Link between Cancer Genetics and Chemotherapy. Cell 2002, 108, 153-164.
90. Attardi, L. D.; Jacks, T. The Role of p53 in Tumor Suppression: Lessons from Mouse Models. Cell. Mol. Life Sci. 1999, 55, 48-63.
91. Ryan, K. M.; Phillips, A. C.; Vousden, K. H. Regulation and Function of p53 Tumor Suppressor Protein. Curr. Opin. Cell Biol. 2001, 13, 332-337.
92. Datta, S. R.; Brunet, A.; Greenberg, M. E. Cellular Survival: a Play in Three Akts. Genes Dev. 1999, 13, 2905-2927.
93. Schmitt, C. A.; Lowe, S. W. Apoptosis and Therapy. J. Pathol. 1999, 187, 127-137.
94. Deverman, B. E.; Cook, B. L.; Manson, S. R.; Niederhoff, R. A.; Langer, E. M.; Rosova, I.; Kulans, L. A.; Fu, X.; Weinberg, J. S.; Heinecke, J. W.; Roth, K. A.; Weintraub, S. J. Bcl-xL Deamidation is a Critical Switch in the Regulation of the Response to DNA Damage. Cell 2002, 111, 51-62.
95. Sinha, R.; Bansal, M. P.; Ganther, H.; Medina, D. Significance of Selenium-Labeled Proteins for Selenium's Chemopreventive Functions. Carcinogenesis 1993, 14, 1895-1900.
96. Gasparian, A. V.; Yao, Y. J.; Lu, J.; Yemelyanov, A. Y.; Lyakh, L. A.; Slaga, T. J.; Budunova, I. V. Selenium Compounds Inhibit IκB Kinase (IKK) and Nuclear Factor-κB (NF-κB) in Prostate Cancer Cells. Mol. Cancer Ther. 2002, 1, 1079-1087.
97. Ip, C.; Dong, Y.; Ganther, H. E. New Concepts in Selenium Chemoprevention. Cancer Met. Rev. 2002, 21, 281-289.
98. Medina, D.; Oborn, C. J. Differential Effects of Selenium on the Growth of Mouse Mammary Cells In Vitro. Cancer Lett. 1981, 13, 333-344.
99. Webber, M. M.; Perez-Ripoll, E. A.; James, G. T. Inhibitory Effects of Selenium on the Growth of DU-145 Human Prostate Carcinoma Cells In Vitro. Biochem. Biophys. Res. Commun. 1985, 130, 603-609.
100. Lewko, W. M.; McConnell, K. P. Influence of Selenium on the Growth of N-Nitrosomethylurea-Induced Mammary Tumor Cells in Culture. Proc. Soc. Exp. Biol. Med. 1985, 180, 33-38.
101. Fico, M. E.; Poirier, K. A.; Watrach, A. M.; Watrach, M. A.; Milner, J. A. Differential Effects of Selenium on Normal and Neoplastic Canine Mammary Cells. Cancer Res. 1986, 46, 3384-3388.
102. Zhu, S.; Gray, T. E.; Nettesheim, P. The Effect of Sodium Selenite on Cell Proliferation and Transformation of Primary Rat Tracheal Epithelial Cells. Carcinogenesis 1992, 13, 1725-1729.
103. Menter, D. G.; Sabichi, A. L.; Lippman, S. M. Selenium Effects on Prostate Cell Growth. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 1171-1182.
104. Ghose, A.; Fleming, J.; El-Bayoumy, K.; Harrison, P. R. Enhanced Sensitivity of Human Oral Carcinomas to Induction of Apoptosis by Selenium Compounds: Involvement of Mitogen-Activated Protein Kinase and Fas Pathways. Cancer Res. 2001, 61, 7479-7487.
105. Shen, C. L.; Song, W.; Pence, B. C. Interactions of Selenium Compounds With Other Antioxidants in DNA Damage and Apoptosis in Human Normal Keratinocytes. Cancer Epidemiol. Biomarkers Prev. 2001, 10, 385-390.
106. Ip, C.; Thompson, H. J.; Ganther, H. E. Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Normal and Premalignant Cells of the Rat Mammary Gland. Cancer Epidemiol. Biomarkers Prev. 2000, 9, 49-54.
107. Whanger, P. D. Selenocompounds in Plants and Animals and Their Biological Significance. J. Am. Coll. Nutr. 2002, 21, 223-232.
108. Thompson, H. J.; Wilson, A.; Lu, J.; Singh, M.; Jiang, C.; Upadhyaya, P. ; El-Bayoumy, K.; Ip, C. Comparison of the Effects of an Organic and an Inorganic Form of Selenium on a Mammary Carcinoma Cell Line. Carcinogenesis 1994, 15, 183-186.
109. Zhong, W.; Oberley, T. D. Redox-Mediated Effects of Selenium on Apoptosis and Cell Cycle in the LNCaP Human Prostate Cancer Cell Line. Cancer Res. 2001, 61, 7071-7078.
110. 3. Biol. Trace Elem. Res. 2002, 85, 241-254.
111. Sundaram, N.; Pahwa, A. K.; Ard, M. D.; Lin, N.; Perkins, E.; Bowles, A. P., Jr. Selenium Causes Growth Inhibition and Apoptosis in Human Brain Tumor Cell Lines. J. Neurooncol. 2000, 46, 125-133.
112. Shilo, S.; Aronis, A.; Komarnitsky, R.; Tirosh, O. Selenite Sensitizes Mitochondrial Permeability Transition Pore Opening In Vitro and In Vivo: a Possible Mechanism for Chemo-protection. Biochem. J. 2003, 370, 283-290.
113. Stewart, M. S.; Spallholz, J. E.; Neldner, K. H.; Pence, B. C. Selenium Compounds Have Disparate Abilities to Impose Oxidative Stress and Induce Apoptosis. Free Radic. Biol. Med. 1999, 26, 42-48.
114. Shen, H. M.; Yang, C. F.; Ong, C. N. Sodium Selenite-Induced Oxidative Stress and Apoptosis in Human Hepatoma HepG2 Cells. Int. J. Cancer 1999, 81, 820-828.
115. Cho, D. Y.; Jung, U.; Chung, A. S. Induction of Apoptosis by Selenite and Selenodiglutathione in HL-60 Cells: Correlation With Cytotoxicity. Biochem. Mol. Biol. Int. 1999, 47, 781-793.
116. Zhu, Z.; Kimura, M.; Itokawa, Y.; Aoki, T.; Takahashi, J. A.; Nakatsu, S.; Oda, Y.; Kikuchi, H. Apoptosis Induced by Selenium in Human Glioma Cell Lines. Biol. Trace Elem. Res. 1996, 54, 123-134.
117. Stewart, M. S.; Davis, R. L.; Walsh, L. P.; Pence, B. C. Induction of Differentiation and Apoptosis by Sodium Selenite in Human Colonic Carcinoma Cells (HT29). Cancer Lett. 1997, 117, 35-40.
118. Jiang, C.; Wang, Z.; Ganther, H.; Lu, J. Distinct Effects of Methylseleninic Acid Versus Selenite on Apoptosis, Cell Cycle, and Protein Kinase Pathways in DU145 Human Prostate Cancer Cells. Mol. Cancer Ther. 2002, 1, 1059-1066.
119. Garberg, P.; Stahl, A.; Warholm, M.; Hogberg, J. Studies of the Role of DNA Fragmentation in Selenium Toxicity. Biochem. Pharmacol. 1988, 37, 3401-3406.
120. Jiang, C.; Wang, Z.; Ganther, H. E.; Lu, J. Caspases as Key Executors of Methyl Selenium-Induced Apoptosis (anoikis) of DU-145 Prostate Cancer Cells. Cancer Res. 2001, 61, 3062-3070.
121. Park, H. S.; Park, E.; Kim, M. S.; Ahn, K.; Kim, I. Y.; Choi, E. J. Selenite Inhibits the C-Jun N-Terminal Kinase/Stress-Activated Protein Kinase (JNK/SAPK) Through a Thiol Redox Mechanism. J. Biol. Chem. 2000, 275, 2527-2531.
122. He, Q.; Rashid, A.; Rong, R.; Hillman, M. J.; Huang, Y.; Sheikh, M. S. Death Receptor 5 Regulation During Selenium-Mediated Apoptosis in Human Prostate Cancer Cells. Cancer Biol. Ther. 2002, 1, 287-290.
123. Sinha, R.; Said, T. K.; Medina, D. Organic and Inorganic Selenium Compounds Inhibit Mouse Mammary Cell Growth in Vitro by Different Cellular Pathways. Cancer Lett. 1996, 107, 277-284.
124. Kuchan, M. J.; Milner, J. A. Influence of Intracellular Glutathione on Selenite-Mediated Growth Inhibition of Canine Mammary Tumor Cells. Cancer Res. 1992, 52, 1091-1095.
125. Kuchan, M. J.; Milner, J. A. Influence of Supplemental Glutathione on Selenite-Mediated Growth Inhibition of Canine Mammary Cells. Cancer Lett. 1991, 57, 181-186.
126. Spallholz, J. E. Free Radical Generation by Selenium Compounds and Their Prooxidant Toxicity. Biomed. Environ. Sci. 1997, 10, 260-270.
127. Hainaut, P.; Milner, J. Redox Modulation of p53 Conformation and Sequence-Specific DNA Binding In Vitro. Cancer Res. 1993, 53, 4469-4473.
128. Qiu, X.; Forman, H. J.; Schonthal, A. H.; Cadenas, E. Induction of p21 Mediated by Reactive Oxygen Species Formed During the Metabolism of Aziridinylbenzoquinones by HCT116 Cells. J. Biol. Chem. 1996, 271, 31915-31921.
129. Abate, C.; Patel, L.; Rauscher, F. J., III; Curran, T. Redox Regulation of Fos and Jun DNA-Binding Activity In Vitro. Science 1990, 249, 1157-1161.
130. Toledano, M. B.; Leonard, W. J. Modulation of Transcription Factor NF-κB Binding Activity by Oxidation-Reduction In Vitro. Proc. Natl. Acad. Sci. U.S.A. 1991, 88, 4328-4332.
131. Yoon, S. O.; Kim, M. M.; Chung, A. S. Inhibitory Effect of Selenite on Invasion of HT1080 Tumor Cells. J. Biol. Chem. 2001, 276, 20085-20092.
132. Handel, M. L.; Watts, C. K.; DeFazio, A.; Day, R. O.; Sutherland, R. L. Inhibition of AP-1 Binding and Transcription by Gold and Selenium Involving Conserved Cysteine Residues in Jun and Fos. Proc. Nail. Acad. Sci. U.S.A. 1995, 92, 4497-4501.
133. Medina, D.; Shepherd, F. Selenium-Mediated Inhibition of 7,12-Dimethylbenz[a]Anthracene-induced Mouse Mammary Tumorigenesis. Carcinogenesis 1981, 2, 451-455.
134. Hiraoka, K.; Komiya, S.; Hamada, T.; Zenmyo, M.; Inoue, A. Osteosarcoma Cell Apoptosis Induced by Selenium. J. Orthop. Res. 2001, 19, 809-814.
135. Poirier, K. A.; Milner, J. A. Factors Influencing the Antitumorigenic Properties of Selenium in Mice. J. Nutr. 1983, 113, 2147-2154.
136. Yan, L.; Spallholz, J. E. Generation of Reactive Oxygen Species From the Reaction of Selenium Compounds With Thiols and Mammary Tumor Cells. Biochem. Pharmacol. 1993, 45, 429-437.
137. Forrest, V. J.; Kang, Y. H.; McClain, D. E.; Robinson, D. H.; Ramakrishnan, N. Oxidative Stress-Induced Apoptosis Prevented by Trolox. Free Radic. Biol. Med. 1994, 16, 675-684.
138. 2 Toxicity. Carcinogenesis 1995, 16, 1579-1584.
139. Ip, C.; Zhu, Z.; Thompson, H. J.; Lisk, D.; Ganther, H. E. Chemoprevention of Mammary Cancer With Se-Allylselenocysteine and Other Selenoamino Acids in the Rat. Anticancer Res. 1999, 19, 2875-2880.
140. Zhu, Z.; Jiang, W.; Ganther, H. E.; Ip, C.; Thompson, H. J. In Vitro Effects of Se-Allylselenocysteine and Se-Propylselenocysteine on Cell Growth, DNA Integrity, and Apoptosis. Biochem. Pharmacol. 2000, 60, 1467-1473.
141. Jiang, W.; Zhu, Z.; Ganther, H. E.; Ip, C.; Thompson, H. J. Molecular Mechanisms Associated with Se-Allylselenocysteine Regulation of Cell Proliferation and Apoptosis. Cancer Lett. 2001, 162, 167-173.
142. Muller, A.; Cadenas, E.; Graf, P.; Sies, H. A Novel Biologically Active Seleno-Organic Compound-1. Glutathione Peroxidase-Like Activity In Vitro and Antioxidant Capacity of PZ 51 (Ebselen). Biochem. Pharmacol. 1984, 33, 3235-3239.
143. Yang, C.F.; Liu, J.; Wasser, S.; Shen, H. M.; Tan, C. E.; Ong, C. N. Inhibition of Ebselen on A flatoxin B(1)-Induced Hepatocarcinogenesis in Fischer 344 Rats. Carcinogenesis 2000, 21, 2237-2243.
144. Ip, C.; Ganther, H. E. Activity of Methylated Forms of Selenium in Cancer Prevention. Cancer Res. 1990, 50, 1206-1211.
145. Yang, C. F.; Shen, H. M.; Ong, C. N. Intracellular Thiol Depletion Causes Mitochondrial Permeability Transition in Ebselen-Induced Apoptosis. Arch. Biochem. Biophys. 2000, 380, 319-330.
146. Liu, S.; Shia, D.; Liu, G.; Chen, H.; Liu, S.; Hu, Y. Roles of Se and NO in Apoptosis of Hepatoma Cells. Life Sci. 2000, 68, 603-610.
147. Ip, C.; Thompson, H. J.; Zhu, Z.; Ganther, H. E. In Vitro and In Vivo Studies of Methylseleninic Acid: Evidence that a Monomethylated Selenium Metabolite is Critical for Cancer Chemoprevention. Cancer Res. 2000, 60, 2882-2886.
148. Ip, C.; Ganther, H E. In Cancer Chemoprevention; Wattenberg, L; Lipkin, M.; Boone, C. W.; Kellof, G. J. Eds.; CRC Press: FL, 1992, pp. 479-488.
149. Ip, C.; Hayes, C.; Budnick, R. M.; Ganther, H. E. Chemical Form of Selenium, Critical Metabolites, and Cancer Prevention. Cancer Res. 1991, 51, 595-600.
150. Ganther, H. E. Pathways of Selenium Metabolism Including Respiratory Excretory Products. J. Am. Coll. Toxicol. 1986, 5, 1-5.
151. Sinha, R.; Unni, E.; Ganther, H. E.; Medina, D. Methylseleninic Acid, a Potent Growth Inhibitor of Synchronized Mouse Mammary Epithelial Tumor Cells In Vitro. Biochem. Pharmacol. 2000, 61, 311-317.
152. Andreadou, I.; Menge, W. M.; Commandeur, J. N.; Worthington, E. A.; Vermeulen, N. P. Synthesis of Novel Se-Substituted Selenocysteine Derivatives as Potential Kidney Selective Prodrugs of Biologically Active Selenol Compounds: Evaluation of Kinetics of Beta-Elimination Reactions in Rat Renal Cytosol. J. Med. Chem. 1996, 39, 2040-2046.
153. Sinha, R.; Medina, D. Inhibition of Cdk2 Kinase Activity by Methylselenocysteine in Synchronized Mouse Mammary Epithelial Tumor Cells. Carcinogenesis 1997, 18, 1541-1547.
154. Unni, E.; Singh, U.; Ganther, H.E.; Sinha, R. Se-Methylselenocysteine Activates Caspase-3 in Mouse Mammary Epithelial Tumor Cells In Vitro. Biofactors 2001, 14, 169-177.
155. Kim, T.; Jung, U.; Cho, D. Y.; Chung, A. S. Se-Methylselenocysteine Induces Apoptosis Through Caspase Activation in HL-60 Cells. Carcinogenesis 2001, 22, 559-565.
156. Jung, U.; Zheng, X.; Yoon, S. O; Chung, A. S. Se-Methylselenocysteine Induces Apoptosis Mediated by Reactive Oxygen Species in HL-60 Cells. Free Radic. Biol. Med. 2001, 31, 479-489.
157. Yeo, J. K.; Cha, S. D.; Cho, C. H.; Kim, S. P.; Cho, J. W.; Baek, W.K.; Suh, M. H.; Kwon, T. K.; Park, J.W.; Suh, S. I. Se-Methylselenocysteine Induces Apoptosis through Caspase Activation and Bax Cleavage Mediated by Calpain in SKOV-3 Ovarian Cancer Cells. Cancer Lett. 2002, 182, 83-92.
158. Wang, Z.; Jiang, C., Ganther, H. E.; Lu, J. Antimitogenic and Proapoptotic Activities of Methylseleninic Acid in Vascular Endothelial Cells and Associatcd Effects on PI3K-AKT, ERK, JNK and p38 MAPK Signaling. Cancer Res. 2001, 61, 7171-7178.
159. Dong, Y.; Ganther, H. E.; Stewart, C.; Ip, C. Identification of Molecular Targets Associated with Selenium-Induced Growth Inhibition in Human Breast Cells Using cDNA Microarrays. Cancer Res. 2002, 62, 708-714.
160. Jiang, C.; Ganther, H. E.; Lu, J. Monomethyl Selenium-Specific Inhibition of MMP-2 and VEGF Expression: Implications for Angiogenic Switch Regulation. Mol. Carcinog. 2000, 29, 236-250.
161. 2 Cells. Free Radic. Biol. Med. 2002, 33, 552-561.
162. Dong, Y.; Ip, C.; Ganther, H. E. Evidence of a Field Effect Associated with Mammary Cancer Chemoprevention by Methylseleninic Acid. Anticancer Res. 2002, 22, 27-32.
163. Dong, Y.; Zhang, H.; Hawthorn, L.; Ganther, H. E.: Ip, C. Delineation of the Molecular Basis for Selenium-Induced Growth Arrest in Human Prostate Cancer Cells by Oligonucleotide Array. Cancer Res. 2003, 63, 52-59.
164. Wang, Z.; Jiang, C.; Lu, J. Induction of Caspase-Mediated Apoptosis and Cell-Cycle GI Arrest by Selenium Metabolite Methylselenol. Mol. Carcinog. 2002, 34, 113-120.
165. Miki, K.; Xu, M.; Gupta, A.; Ba, Y.; Tan, Y.; Al-Refaie, W.; Bouvet, M.; Makuuchi, M.; Moossa, A. R; Hoffman, R. M. Methioninase Cancer Gene Therapy with Selenomethionine as Suicide Prodrug Substratc. Cancer Res. 2001, 61, 6805-6810.
166. 3/LDA-Assisted Reaction of 3-selena-4-pentyn-1-one as Potential Antitumor Agents. Org. Lett. 2001, 3, 1705-1707.
167. El-Bayoumy, K.; Rao, C, V.; Reddy, B. S. Multiorgan Sensitivity to Anticarcinogenesis by the Organoselenium 1,4-Phenylenebis (Methylene) Selenocyanate. Nutr. Cancer 2001, 40, 18-27.
168. Reddy, B. S.; Rivenson, A.; Kulkarni, N.; Upadhyaya, P.; El-Bayoumy, K. Chemoprevention of Colon Carcinogenesis by the Synthetic Organoselenium Compound 1,4-Phenylenebis (Methylene) Selenocyanate. Cancer Res. 1992, 52, 5635-5640.
169. Min Mouse Model by 1,4-Phenylenebis (Methylene) Selenocyanate. Carcinogenesis 2000, 21, 617-621.
170. El-Bayoumy, K.; Upadhyaya, P.; Desai, D. H.; Amin, S.; Hecht, S. S. Inhibition of 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone Tumorigenicity in Mouse Lung by the Synthetic Organoselenium Compound, 1,4-Phenylenebis (Methylene) Selenocyanate. Carcinogenesis 1993, 14, 1111-1113.
171. Rosa, J. G.; Prokopczyk, B.; Desai, D. H.; Amin, S. G.; El-Bayoumy, K. Elevated 8-Hydroxy-2′-Deoxyguanosine Levels in Lung DNA of A/J Mice and F344 Rats Treated With 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone and Inhibition by Dietary 1,4-Phenylenebis (Methylene) Selenocyanate. Carcinogenesis 1998, 19, 1783-1788.
172. Prokopczyk, B.; Rosa, J. G.; Desai, D.; Amin, S.; Sohn, O. S.; Fiala, E. S.; El-Bayoumy, K. Chemoprevention of Lung Tumorigenesis Induced by a Mixture of Benzo(a)Pyrene and 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone by the Organoselenium Compound 1,4-Phenylenebis (Methylene) Selenocyanate. Cancer Lett. 2000, 161, 35-46.
173. Tanaka, T.; Kohno, H.; Murakami, M.; Kagami, S.; El-Bayoumy, K. Suppressing Effects of Dietary Supplementation of the Organoselenium 1,4-Phenylenebis (Methylene) Selenocyanate and the Citrus Antioxidant Auraptene on Lung Metastasis of Melanoma Cells in Mice. Cancer Res. 2000, 60, 3713-3716.
174. El-Bayoumy, K.; Chae, Y. H.; Upadhyaya, P.; Meschter, C.; Cohen, L. A.; Reddy, B. S. Inhibition of 7,12-Dimethylbenz(a) anthracene-Induced Tumors and DNA Adduct Formation in the Mammary Glands of Female Sprague-Dawley Rats by the Synthetic Organoselenium Compound, 1,4-Phenylenebis (Methylene) Selenocyanate. Cancer Res. 1992, 52, 2402-2407.
175. Rao, C. V.; Wang, C. Q.; Simi, B.; Rodriguez, J. G.; Cooma, I.; El-Bayoumy, K.; Reddy, B. S. Chemoprevention of Colon Cancer by a Glutathione Conjugate of 1,4-Phenylenebis (Methylene) Selenocyanate, a Novel Organoselenium Compound with Low Toxicity. Cancer Res. 2001, 61, 3647-3652.
176. Lee, S. K.; Heo, Y. H.; Steele, V. E.; Pezzuto, J. M. Induction of Apoptosis by 1,4-Phenylenebis (Methylene) Selenocyanate in Cultured Human Colon Cancer Cells. Anticancer Res. 2002, 22, 97-102.
177. Tillotson, J. K.; Upadhyaya, P.; Ronai, Z. Inhibition of Thymidine Kinase in Cultured Mammary Tumor Cells by the Chemopreventive Organoselenium Compound, 1,4-Phenylenebis (Methylene) Selenocyanate. Carcinogenesis 1994, 15, 607-610.
178. Ronai, Z.; Tillotson, J. K.; Traganos, F.; Darzynkiewicz, Z.; Conaway, C. C.; Upadhyaya, P.; El-Bayoumy, K. Effects of Organic and Inorganic Selenium Compounds on Rat Mammary Tumor Cells. Int. J. Cancer 1995, 63, 428-434.
179. Koketsu, M.; Ishihara, H.; Wu, W.; Murakami, K.; Saiki, I. 1, 3-Selenazine Derivatives Induce Cytotoxicity and DNA Fragmentation in Human HT-1080 Fibrosarcorna Cells. Eur. J. Pharm. Sci. 1999, 9, 157-161.
180. Wu, W.; Murakami, K.; Koketsu, M.; Yamada, Y.; Saiki, I. Induction of Apoptosis in Human Gastric Adenocarcinoma Cells by Two Novel Organoselenium Compounds, TS-2 and TS-6. Anticancer Res. 1999, 19, 5375-5381.
181. Cho, S. I.; Koketsu, M.; Ishihara, H.; Matsushita, M.; Nairn, A. C.; Fukazawa, H.; Uehara, Y. Novel Compounds, '1,3-Selenazine Derivatives' as Specific Inhibitors of Eukaryotic Elongation Factor-2 Kinase. Biochim. Biophys. Acta 2000,1475, 207-215.
182. El-Bayoumy, K.; Richie, J. P. Jr.; Boyiri, T.; Komninou, D.; Prokopczyk, B.; Trushin, N.; Kleinman, W.; Cox, J.; Pittman, B.; Colosimo, S. Influence of Selenium-Enriched Yeast Supplementation on Biomarkers of Oxidative Damage and Hormone Status in Healthy Adult Males: A Clinical Pilot Study. Cancer Epidemiol. Biomarkers Prev. 2002, 11, 1459-1465.
183. Griffin, A. C.; Jacobs, M. M. Effects of Selenium on Azo Dye Hepatocarcinogenesis. Cancer Lett. 1977, 3, 177-181.
184. Ip, C., Birringer, M.; Block, E.; Kotrebai, M.; Tyson, J. F.; Uden, P. C.; Lisk, D. J. Chemical Speciation Influences Comparative Activity of Selenium-Enriched Garlic and Yeast in Mammary Cancer Prevention. J. Agric. Food Chem. 2000, 48, 2062-2070.
185. Bergman, K.; Slanina, P. Effects of Dietary Selenium Compounds on Benzo(a)Pyrene-Induced Forestomach Tumours and Whole-Blood Glutathione Peroxidase Activities in C3H Mice. Anticancer Res. 1986, 6, 785-790.
186. Das, A.; Desai, D.; Pittman, B.; Amin, S.; El-Bayoumy, K. Comparison of the Chemopreventive Efficacies of 1,4-Phenylenebis (Methylene) Selenocyanate (p-XSC) and Selenium-Enriched Yeast on 4-(Methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK)-Induced Lung Tumorigenesis in A/J Mouse. Nutr. Cancer 2003, 46, 179-185.
187. McCormick, D. L.; Johnson, W. D.; Lubet, R. A.; Steele, V. E.; Bosland, M. C. Null Activity of Selenized Yeast as a Chemopreventive Agent in the Rat Prostate. Proc. Am. Assoc. Cancer Res. 2003, 94. Abstract #3895.
188. Vadgama, J. V.; Wu, Y.; Shen, D.; Hsia, S.; Block, J. Effect of Selenium in Combination with Adriamycin or Taxol on Several Different Cancer Cells. Anticancer Res. 2000, 20, 1391-1414.
189. Ip, C.; Ganther, H. E. Comparison of Selenium and Sulfur Analogs in Cancer Prevention. Carcinogenesis 1992, 13, 1167-1170.
190. Yan, L.; Yee, J. A.; Li, D.; McGuire, M. H.; Graef, G. L. Dietary Supplementation of Selenomethionine Reduces Metastasis of Melanoma Cells in Mice. Anticancer Res. 1999, 19, 1337-1342.
191. Reddy, B. S.; Hirose, Y.; Lubet, R. A.; Steele, V. E.; Kelloff, G. J.; Rao, C. V. Lack of Chemopreventive Efficacy of DL-Selenomethionine in Colon Carcinogenesis. Int. J. Mol. Med. 2000, 5, 327-330.
192. Prokopczyk, B.; Amin, S.; Desai, D. H.; Kurtzke, C.; Upadhyaya, P.; El Bayoumy, K. Effects of 1,4-Phenylenebis (Methylene) Selenocyanate and Selenomethionine on 4-(Methylnitrosamino)-1-(3-Pyridyl)-1-Butanone-Induced Tumorigenesis in A/J Mouse Lung. Carcinogenesis 1997, 18, 1855-1857.
193. McCormick, D. L.; Rao, K. V. Chemoprevention of Hormone-Dependent Prostate Cancer in the Wistar-Unilever Rat. Eur. Urol. 1999, 35, 464-467.
194. Lane, H. W.; Teer, P.; Dukes, J.; Johnson, J.; White, M. T. The Effect of Four Chemical Forms of Selenium on Mammary Tumor Incidence in BALB/c Female Mice Treated With 7-12-Dimethylbenz[a]Anthracene. Cancer Lett. 1990, 50, 39-44.
195. Waters, D. J.; Shen, S.; Cooley, D. M.; Bostwick, D. G.; Qian, J.; Combs, G. F. Jr.; Glickman, L. T.; Oteham, C.; Schlittler, D.; Morris, J. S. Effects of Dietary Selenium Supplementation on DNA Damage and Apoptosis in Canine Prostate. J. Natl. Cancer Inst. 2003, 95, 237-241.
196. Redman, C.; Scott, J. A.; Baines, A. T.; Basye, J. L.; Clark, L. C.; Calley, C.; Roe, D.; Payne, C. M.; Nelson, M. A. Inhibitory Effect of Selenomethionine on the Growth of Three Selected Human Tumor Cell Lines. Cancer Lett. 1998, 125, 103-110.
197. Redman, C.; Xu, M. J.; Peng, Y.M.; Scott, J. A.; Payne, C.; Clark, L. C. ; Nelson, M. A. Involvement of Polyamines in Selenomethionine Induced Apoptosis and Mitotic Alterations in Human Tumor Cells. Carcinogenesis 1997, 18, 1195-1202.
198. Chigbrow, M.; Nelson, M. Inhibition of Mitotic Cyclin B and cdc2 Kinase Activity by Selenomethionine in Synchronized Colon Cancer Cells. Anticancer Drug 2001, 12, 43-50.
199. Venkateswaran, V.; Klotz, L. H.; Fleshner, N. E. Selenium Modulation of Cell Proliferation and Cell Cycle Biomarkers in Human Prostate Carcinoma Cell Lines. Cancer Res. 2002, 62, 2540-2545.
200. Yang, M.; Sytkowski, A. J. Differential Expression and Androgen Regulation of the Human Selenium-Binding Protein Gene HSP56 in Prostate Cancer Cells. Cancer Res. 1998, 58, 3150-3153.
201. Gudkov, A. V. Converting p53 From a Killer into a Healer. Nat. Med. 2002, 8, 1196-1198.
202. Baines, A.; Taylor-Parker, M.; Goulet, A. C.; Renaud, C.; Gerner, E. W.; Nelson, M. A. Selenomethionine Inhibits Growth and Suppresses Cyclooxygenase-2 (COX-2) Protein Expression in Human Colon Cancer Cell Lines. Cancer Biol. Ther. 2002, 1, 370-374.
203. Parker, M. T.; Gerner, E. W. Polyamine-Mediated Post-Transcriptional Regulation of COX-2. Biochimie 2002, 84, 815-819.
204. Manning, G.; Whyte, D. B.; Martinez, T.; Hunter, T.; Sudarsanam, S. The Protein Kinase Complement of the Human Genome. Science 2002, 298, 1912-1934.
205. Klein, E. A.; Thompson, I. M.; Lippman, S. M.; Goodman, P. J.; Albanes, D.; Taylor, P. R.; Coltman, C.; SELECT: The Selenium and Vitamin E Cancer Prevention Trial: Rationale and Design. Prost. Cancer Prost. Dis. 2000, 3, 145-151
206. Hoque, A.; Albanes, D.; Lippman, S. M.; Spitz, M. R.; Taylor, P. R.; Klein, E. A.; Thompson, I. M.; Goodman, P.; Stanford, J. L.; Crowley, J. J.; Coltman, C. A.; Santella, R. M. Molecular Epidemiologic Studies Within the Selenium and Vitamin E Cancer Prevention Trial (SELECT). Cancer Causes Control 2001, 12, 627-33.
207. Mugesh, G.; Du Mont, W. W.; Sics, H. Chemistry of Biologically Important Synthetic Organoselenium Compounds. Chem. Rev. 2001, 101, 2125-2179.